Aarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year rise in Q1 FY27 net profit to Rs 76.14 crore. Revenue surged 38.7% to Rs 535.79 crore, while the company also approved a Rs 149-crore capex plan to expand manufacturing capacity.
Aarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year rise in Q1 FY27 net profit to Rs 76.14 crore. Revenue surged 38.7% to Rs 535.79 crore, while the company also approved a Rs 149-crore capex plan to expand manufacturing capacity.
<iframe src="https://hindustansphere.com/embed/cluster/3c53dc78f41268ee4da94300e5d451345b1d9038" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore"></iframe>
